Quadrivalent Booster Vaccine Market Study
A French multinational pharmacy company wanted to understand the utilization trends and consumption patterns of quadrivalent ‘DTapIPV’ combination vaccines for use as booster dose (Tetraxim, Infanrix Tetra/IPV), and to conclude if their vaccine was the market leader among quadrivalent booster dose (pre-school) vaccines. They required the following: Demand Analysis of The Vaccine Consumption Volumes Vaccine Volumes by Region and Country Vaccine Volumes by Public and Private Markets Analysis of Brand Proportions Of Quadrivalent Vaccine Brands Across Major Countries
Research findings were delivered to the client as a custom report covering – Volumes of DTP vaccines by Type of Pertussis Antigens (wP and aP) Public and Private markets For Quadrivalent booster Vaccine Indicators For calculating Quadrivalent booster vaccine Volumes Calculation Of Volumes Of Quadrivalent booster Vaccine Public & Private Markets For Quadrivalent booster Vaccines Analysis Of Indicators For Calculating Quadrivalent booster Vaccine Volumes In Public And Private Markets Volumes of Quadrivalent booster Vaccines Brand Analysis of Quadrivalent booster Vaccines
We conducted secondary research through: World Health Organization (WHO), United Nations Children's –Fund (UNICEF), GAVI Alliance Ministry of Health resources Magazines, journals, news sources, research papers and blogs Press Releases Regulatory Filings Other sources found relevant during the research study
The client was very satisfied with the findings of our study and was able to gain insights on the market growth potential.